您现在的位置是:主页 > 威尼斯人真钱棋牌 > 降價藥品在路上33品種入選第二批國家集中采購名單

降價藥品在路上33品種入選第二批國家集中采購名單
2020-01-06 22:38   来源:  www.ndigbotvnews.com   评论:0 点击:

降價藥品在路上33品種入選第二批國家集中采購名單央視網消息:新的一年,看病用藥也有了好消息。國家組織藥

  央視網消息:新的一年,看病用藥也有了好消息。國家組織藥品集中采購和使用聯合采購辦公室日前發布全國藥品集中采購文件,33個品種入選第二批國家藥品集中采購名單,又一波降價藥品已經“在路上”。

CCTV net news: the new year, see a doctor medication also have good news. The Office of Centralized Drug Purchase and Use of the State Organization has issued a national centralized drug purchase document,33 varieties have been selected as the second batch of national centralized drug purchase list, and another wave of reduced prices of drugs has been \"on the way.\"

  第二批國家藥品集中采購名單涵蓋高血壓、糖尿病等重大慢性病用藥,以及抗腫瘤和罕見病用藥。采購目錄顯示,阿卡波糖等口服降糖藥物;奧美沙坦酯等高血壓用藥;治療罕見病——肺動脈高壓的藥物安立生坦片,還有抗癌藥替吉奧、阿比特龍等藥品入圍。

The second batch of national drug centralized purchase list covers hypertension, diabetes and other major chronic diseases, as well as anti-tumor and rare disease drugs. According to the purchase catalogue, acarbose and other oral hypoglycemic drugs; omesartan ester and other hypertension drugs; treatment of rare diseases-pulmonary arterial hypertension drugs anlishengtan tablets, as well as anti-cancer drugs tegeo, abitron and other drugs shortlisted.

  按照集中采購工作安排,2020年1月17日將開標產生擬中選結果,全國各地患者將于今年4月份用上第二批集中帶量采購中選藥品。

According to the centralized procurement work arrangement, the bid opening will produce the result of the proposed selection on January 17,2020, and patients from all over the country will use the second batch of concentrated belt quantity to purchase the selected drugs in April this year.

  一些未納入醫保目錄的自費品種此次也加入集中采購。業內人士指出,這意味著自費藥品也將感受到集中帶量采購帶來的降價“壓力”。

Some of the self-financed varieties that are not included in the health care catalogue are also joining the centralized purchase this time. Industry insiders point out that this means that self-financed medicines will also feel the \"pressure\" to reduce prices brought on by concentrated purchases.

  以帶量采購的模式引導藥品降價,已成為一種趨勢。近日,全國5萬多家中小型藥店組成聯盟,通過全國零售藥店的銷售量和藥企談判,實現“以量換價”,降低藥店經營藥品的價格。讓老百姓吃上便宜的放心藥,讓藥店獲得規模和利潤雙增長,全面助推醫藥分家實施進程。

It has become a trend to guide the price reduction of drugs by the mode of purchasing with quantity. Recently, more than 50,000 small and medium-sized pharmacies across the country formed an alliance to achieve \"quantity-for-price\" through sales volume of national retail pharmacies and negotiations among pharmaceutical enterprises, and to reduce the price of drugs sold in pharmacies. Let common people take cheap rest assured medicine, let drugstore obtain scale and profit double growth, promote the implementation process of medicine separation in an all-round way.


相关热词搜索:

上一篇:iPhone12細節曝光蘋果解決這痛點!贊
下一篇:清華、北大發布就業報告,清華25%畢業生就業于廣東

分享到: